Curated News
By: NewsRamp Editorial Staff
September 08, 2025

NRx Pharmaceuticals Expands Mental Health Network with Dura Medical Acquisition

Reddit View History of this news story on GitHub
Original Source

TLDR

  • NRx Pharmaceuticals gains a strategic advantage by acquiring revenue-generating Dura Medical, expanding its Florida network and enhancing its interventional psychiatry service offerings.
  • HOPE Therapeutics acquired Dura Medical, which provides Ketamine Infusion Therapy and Transcranial Magnetic Stimulation for depression, PTSD, and chronic pain treatments.
  • This acquisition expands access to advanced mental health treatments, improving care for patients with depression, PTSD, and chronic pain in Florida communities.
  • NRx Pharmaceuticals' subsidiary acquired Dura Medical, founded by a U.S. Army veteran, expanding its network with innovative treatments like Ketamine Infusion Therapy.

Impact - Why it Matters

This acquisition matters because it represents a significant step forward in expanding access to advanced mental health treatments, particularly for conditions like depression, PTSD, and chronic pain that affect millions globally. By integrating revenue-generating clinical services with innovative pharmaceutical development, NRx Pharmaceuticals is poised to deliver more comprehensive and effective care options. For patients, this could mean quicker access to cutting-edge therapies such as ketamine infusion and transcranial magnetic stimulation, which have shown promise in treating severe mental health issues where traditional methods fall short. Investors and the healthcare industry should take note as this strategic move not only enhances NRx's market position but also addresses the growing mental health crisis, potentially improving outcomes and reducing the societal burden of these debilitating conditions.

Summary

NRx Pharmaceuticals (NASDAQ: NRXP), a clinical-stage biopharmaceutical company, has announced that its subsidiary HOPE Therapeutics Inc. has successfully acquired Dura Medical, a revenue-generating and EBITDA-positive provider of interventional psychiatry services in Florida. Dura Medical, founded in 2018 by U.S. Army veteran Stephen Durand, specializes in treating depression, PTSD, suicidality, anxiety, and chronic pain through advanced therapies including Ketamine Infusion Therapy, Transcranial Magnetic Stimulation, Spravato®, Stellate Ganglion Blocks, and traditional psychiatry. This strategic acquisition, combined with pending deals for Neurospa TMS and Cohen and Associates, will expand HOPE's network to over eight locations across Florida, significantly enhancing its clinical footprint and service capabilities in the mental health sector.

NRx Pharmaceuticals is developing innovative therapeutics based on its NMDA platform, focusing on central nervous system disorders such as suicidal depression, chronic pain, and PTSD. Key products include NRX-100, a preservative-free intravenous ketamine with Fast Track Designation for suicidal ideation, and NRX-101, an oral D-cycloserine/lurasidone combination with Breakthrough Therapy Designation for suicidal bipolar depression. The company has recently filed regulatory applications, including an Abbreviated New Drug Application (ANDA) and a New Drug Application for NRX-100, positioning it as a leader in novel psychiatric treatments. This acquisition aligns with NRx's mission to advance cutting-edge mental health solutions and expand access to effective interventional therapies.

The news was disseminated through PsychedelicNewsWire, part of the Dynamic Brand Portfolio at IBN, which provides extensive distribution and communication services for the psychedelics sector. For investors and stakeholders, updates on NRXP are available in the company's newsroom, ensuring transparency and ongoing engagement. This development underscores NRx's commitment to growth and innovation in mental healthcare, leveraging both pharmaceutical development and clinical service expansion to address critical unmet needs in psychiatry.

Source Statement

This curated news summary relied on content disributed by InvestorBrandNetwork (IBN). Read the original source here, NRx Pharmaceuticals Expands Mental Health Network with Dura Medical Acquisition

blockchain registration record for this content.